AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 296: G1077-G1084, 2009. First published March 5, 2009; doi:10.1152/ajpgi.00006.2009
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/5/G1077    most recent
00006.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Motagally, M. A.
Right arrow Articles by Lomax, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motagally, M. A.
Right arrow Articles by Lomax, A. E.

NEUROREGULATION AND MOTILITY

Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis

Mohamed A. Motagally, Shadia Neshat, and Alan E. Lomax

Departments of Physiology and Medicine, Gastrointestinal Diseases Research Unit and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada

Submitted 8 January 2009 ; accepted in final form 26 February 2009

Inflammatory bowel diseases (IBD) are associated with altered neuronal regulation of the gastrointestinal (GI) tract and impairment of norepinephrine release from sympathetic varicosities. The sympathetic innervation of the GI tract modulates motility, blood flow, and secretion, and therefore defective norepinephrine release may contribute to symptom generation in IBD. Accordingly, our aim here was to utilize the mouse model of dextran sulfate sodium (DSS; 5% wt/vol) of IBD to determine how norepinephrine release is reduced during GI inflammation. We hypothesized that the inflammation-induced reduction in norepinephrine release was due to inhibition of voltage-gated Ca2+ current (ICa) in prevertebral sympathetic neurons. We compared [3H]norepinephrine release in the colon and jejunum and ICa amplitude in superior mesenteric ganglion (SMG) neurons from control mice and mice with DSS-induced colitis. Changes to voltage-gated Ca2+ channels were investigated by fura 2-AM Ca2+ imaging, perforated patch-clamp electrophysiology, and real-time PCR. Depolarization-induced norepinephrine release from the inflamed colon and uninflamed jejunum was significantly impaired in mice treated with DSS, as was depolarization-induced Ca2+ influx in SMG neurons. Colitis reduced ICa in SMG neurons by inhibiting {omega}-conotoxin GVIA (300 nM)-sensitive N-type Ca2+ channels. The {omega}-conotoxin GVIA-sensitive component of norepinephrine release was significantly smaller in the colon during colitis. The inhibition of ICa was accompanied by a decrease in mRNA encoding the Ca2+ channel alpha subunit (CaV 2.2) and a rightward shift in the voltage dependence of activation of ICa. These findings suggest that DSS-induced colitis attenuates norepinephrine release in the colon and jejunum due to inhibition of N-type voltage-gated Ca2+ channels. This may contribute to functional alterations in both inflamed and uninflamed regions of the GI tract during inflammation.

sympathetic postganglionic neuron; inflammation; calcium current



Address for reprint requests and other correspondence: A. E. Lomax, Gastrointestinal Diseases Research Unit, Kingston General Hospital, 76 Stuart St., Kingston, Ontario K7L 2V7, Canada (e-mail: lomaxa{at}queensu.ca)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.